Cytiva is a global life sciences leader dedicated to advancing and accelerating therapeutics. With a rich heritage from GE Healthcare Life Sciences and as part of Danaher Corporation, Cytiva provides a broad portfolio of instruments, consumables, software, and services that support customers from discovery to delivery. Their expertise spans research, process development, and manufacturing workflows, enabling the development and production of transformative medicines, including biopharmaceuticals, vaccines, and cell and gene therapies. Cytiva's mission is to help bring new therapies to patients faster by improving the speed, efficiency, and capacity of biopharmaceutical manufacturing.
Serves as a major operational and strategic center, housing leadership, R&D, customer engagement, and administrative functions supporting global initiatives and the Americas market.
State-of-the-art facility within a life sciences campus, likely featuring advanced research and development labs, customer experience centers, and modern office spaces designed for collaboration.
Cytiva fosters a culture of innovation, collaboration, and customer-centricity, strongly influenced by the Danaher Business System (DBS) which emphasizes continuous improvement and impact. Employees are driven by the mission to advance human health.
The Marlborough HQ is a critical node in Cytiva's global network, driving strategy for bioprocessing technologies and solutions, and reflecting its commitment to the North American life sciences ecosystem.
Cytiva maintains a strong global presence with operations spanning the Americas, Europe, Asia-Pacific, the Middle East, and Africa. This extensive network includes R&D centers, state-of-the-art manufacturing facilities, Fast Trak bioprocessing service and training centers, commercial offices, and distribution hubs. Globally, Cytiva supports functions such as research and discovery, bioprocess development, upstream and downstream biomanufacturing solutions (including single-use technologies, cell culture media, chromatography, filtration, and lab essentials), as well as comprehensive services, technical support, and validation.
100 Results Way
Marlborough
Massachusetts
USA
Address: Pollards Wood, Nightingales Lane, Chalfont St Giles, Buckinghamshire, HP8 4SP, UK
Acts as a crucial hub for Cytiva's operations in Europe, Middle East, and Africa (EMEA), supporting regional customer needs, innovation, and business development.
Address: Björkgatan 30, 751 84 Uppsala, Sweden
Critical site for Cytiva's global supply chain and European operations, driving innovation and production of core biopharmaceutical manufacturing technologies used worldwide.
Address: Building 1, No. 1, Huajing Road No. 3, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, China
Supports the rapidly growing biopharmaceutical industry in China and the broader APAC region, providing local expertise, training, and access to Cytiva's technologies.
Address: Plot No. PAP-A-80, Phase-2, MIDC Chakan, Village Vasuli, Tal. Khed, Dist. Pune, Maharashtra, India
Enhances Cytiva's manufacturing capacity for the Indian and Southeast Asian markets, supporting regional biopharmaceutical development and manufacturing with locally produced solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cytiva' leadership includes:
Cytiva has been backed by several prominent investors over the years, including:
Cytiva has focused on strengthening its scientific and specialized business unit leadership. In late 2023, a key appointment was made for the Chief Scientific Officer role. Public information on other C-level executive changes or departures in the past 12 months is limited.
Discover the tools Cytiva uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cytiva, as an operating company of Danaher, typically utilizes a standard corporate email format. The most commonly observed and effective format is combining the employee's first name and last name, separated by a period.
first.last@cytiva.com
Format
john.doe@cytiva.com
Example
90%
Success rate
PR Newswire • May 21, 2024
Cytiva and RoosterBio, Inc. announced a collaboration to optimize human mesenchymal stem/stromal cell (hMSC) bioreactor manufacturing processes. The partnership aims to develop scalable solutions to accelerate the development and commercialization of hMSC-based therapies....more
PR Newswire • April 25, 2024
Cytiva inaugurated a new 11,000 square meter manufacturing facility in Pune, India. This expansion aims to bolster its global manufacturing capabilities for bioprocessing technologies and better serve the growing Indian and broader APAC biopharmaceutical markets....more
Cytiva Newsroom • November 2, 2023
Cytiva announced the appointment of Dr. Keni Geles as its new Chief Scientific Officer. Dr. Geles will be responsible for leading the company's global scientific strategy, fostering innovation, and advancing Cytiva's research and development initiatives....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cytiva, are just a search away.